Capital FM

Malawi assesses efficiency of COVID-19 vaccine ahead of introduction

The Government is revealing that research is underway to assess the efficacy of the Covid-19 vaccine.

This research is also meant to inform government’s decision on which Vaccine to opt for.

Recently some sections of society have been pressing the Chakwera administration to seek expert assessment and recommendation before rolling out any Covid-19 vaccine in the country.

Earlier, health authorities had indicated that Malawi would get the Covid-19 vaccine in the next 3 months to control the rapid spread of the pandemic.

Currently there are 2 types of the COVID19 Vaccine recommended and approved by the World Heath Organization and the Center for Disease Control, which is being administered in various countries around the world

According to Minister of Health Khumbize Kandodo- Chiponda thes research is also meant to inform government’s decision on which Vaccine to opt for between the two.

Government’s announcement of introducing the vaccine in the country however sparked stakeholders’ concerns, following revelations that vaccine manufactures insisted on a disclaimer distancing them from any responsibility for any harm the vaccine might cause to Malawians.

Currently, there is evident public resistance to the pending vaccine, with some people rejecting the vaccine outright on religious and personal grounds as well as fear of life threatening complications.

Responding to the concerns, Kandodo- Chiponda insists the government’s final decision on the vaccine will be guided by recommendations from relevant experts.


READ  John Chilembwe statue to be displayed at Trafalgar Square in London

Related posts

Covid vaccine stocks running out in major cities

Jayne Kaonga

30 arrested in connection to exam leakage

Capital Radio

Committee questions late ADMARC inclusion in AIP

Clement Msiska

Leave a Comment

error: Content is protected !!